Intrinsic value of NovoCure Limited (NVCR)

NovoCure Limited (NVCR) intrinsic value snapshot: our valuation models currently suggest the stock is undervalued, with an estimated 596.7% upside relative to fair value at a market price of $16.30. The dollar intrinsic value (fair value) for NovoCure Limited is derived from DCF, P/E Multiple, and P/S Multiple models—available with Tickerplace Pro for investors comparing market price to modeled fair value.

Intrinsic Value (Fair Value): Unlock fair value

Upside: +596.7%

Margin of Safety: Unlock fair value

Current Price: $16.30

Valuation: Undervalued

Confidence: 9.5/10

Visual Bar

Market Price $16.30Intrinsic Value Locked
Undervalued ✅Fair Value ⚖️Overvalued ❌

How we calculate fair value: We combine DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models to estimate intrinsic value. This figure is for information only - not investment advice - and assumptions may not reflect actual market conditions. We encourage doing your own research or speaking with a financial advisor before making investment decisions.

Intrinsic Value checker

Search our company database (same as the site header), pick a match, or type a ticker to open its intrinsic value analysis.

Is NovoCure Limited (NVCR) undervalued or overvalued?

Based on our intrinsic value models, NovoCure Limited (NVCR) currently looks undervalued with an estimated 596.66% upside relative to fair value at $16.30. Sign in to Tickerplace Pro to view the full dollar fair value estimate and margin of safety.

Fair value vs market price — NovoCure Limited (NVCR)

NovoCure Limited (NVCR) fair value vs market price: our valuation models suggest undervalued positioning with an estimated 596.7% upside relative to intrinsic value at a market price of $16.30. The dollar fair value for NovoCure Limited is calculated from DCF, P/E Multiple, and P/S Multiple models—available with Tickerplace Pro for a full market-price-to-fair-value breakdown and margin of safety.

Frequently Asked Questions - NVCR

What is the intrinsic value of NovoCure Limited (NVCR)?

Our models calculate the intrinsic value of NovoCure Limited (NVCR) using DCF, P/E Multiple, and P/S Multiple approaches based on projected cash flows, growth rate, and discount rate. Sign in to Tickerplace Pro to view the full dollar estimate.

Is NVCR undervalued or overvalued?

Based on our 2026 valuation models, NVCR appears undervalued at its current price of $16.30. Our model suggests 596.7% upside potential.

How is NVCR's intrinsic value calculated?

Tickerplace calculates NVCR's intrinsic value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We project future cash flows, apply a discount rate that reflects investment risk, and compare the resulting fair value estimate to the current market price.

Related companies — intrinsic value

Peers for NVCR: open their intrinsic value pages.

Explore Our Valuation Calculators